Cargando…
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. H...
Autores principales: | Sequeiros, Tamara, Rigau, Marina, Chiva, Cristina, Montes, Melania, Garcia-Grau, Iolanda, Garcia, Marta, Diaz, Sherley, Celma, Ana, Bijnsdorp, Irene, Campos, Alex, Di Mauro, Primiano, Borrós, Salvador, Reventós, Jaume, Doll, Andreas, Paciucci, Rosanna, Pegtel, Michiel, de Torres, Inés, Sabidó, Eduard, Morote, Juan, Olivan, Mireia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354884/ https://www.ncbi.nlm.nih.gov/pubmed/27903962 http://dx.doi.org/10.18632/oncotarget.13634 |
Ejemplares similares
-
Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
por: Sequeiros, Tamara, et al.
Publicado: (2013) -
The Present and Future of Prostate Cancer Urine Biomarkers
por: Rigau, Marina, et al.
Publicado: (2013) -
Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
por: Olivan, M., et al.
Publicado: (2015) -
Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014) -
Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)